We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$63.1B
AUM Growth
+$3.79B
Cap. Flow
-$1.12B
Cap. Flow %
-1.77%
Top 10 Hldgs %
32.11%
Holding
999
New
156
Increased
303
Reduced
370
Closed
127

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$1.35B
2
INSM icon
Insmed
INSM
+$197M
3
HUBB icon
Hubbell
HUBB
+$191M
4
ARGX icon
argenx
ARGX
+$164M
5
SLNO
Soleno Therapeutics
SLNO
+$161M

Sector Composition

Rank Sector Weight
1 Technology 30.31%
2 Healthcare 13.97%
3 Financials 11.89%
4 Consumer Discretionary 9.55%
5 Communication Services 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACHC icon
576
Acadia Healthcare
ACHC
$2.86B
$13.3M 0.02%
538,087
-7,493
-1% -$167K
PRQR icon
577
ProQR Therapeutics
PRQR
$268M
$13.3M 0.02%
6,253,467
-348,471
-5% -$761K
KMI icon
578
Kinder Morgan
KMI
$69.7B
$13.3M 0.02%
+470,154
New +$12.9M
SPLV icon
579
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
$13.2M 0.02%
180,000
+40,000
+29% +$2.92M
ZURA icon
580
Zura Bio
ZURA
$542M
$13.2M 0.02%
+3,045,444
New +$5.48M
L icon
581
Loews
L
$23.7B
$13M 0.02%
129,800
-29,600
-19% -$2.8M
RARE icon
582
Ultragenyx Pharmaceutical
RARE
$2.54B
$12.9M 0.02%
430,000
-1,099,474
-72% -$33M
HRTX icon
583
Heron Therapeutics
HRTX
$94.5M
$12.9M 0.02%
10,239,225
+2,387,225
+30% +$3.78M
CEPF
584
Cantor Equity Partners IV
CEPF
$594M
$12.7M 0.02%
+1,250,000
New +$12.7M
TGNA
585
DELISTED
TEGNA Inc
TGNA
$12.7M 0.02%
+625,000
New +$11.9M
TKO icon
586
TKO Group
TKO
$13.7B
$12.7M 0.02%
62,800
+1,400
+2% +$256K
NBP
587
NovaBridge Biosciences American Depositary Shares
NBP
$197M
$12.6M 0.02%
+3,338,034
New +$11.3M
ADUS icon
588
Addus HomeCare
ADUS
$2.22B
$12.6M 0.02%
106,464
+64,464
+153% +$7.23M
KHC icon
589
Kraft Heinz
KHC
$29.6B
$12.5M 0.02%
478,532
-142,800
-23% -$3.88M
KRP icon
590
Kimbell Royalty Partners
KRP
$1.43B
$12.4M 0.02%
916,466
-75,000
-8% -$1.05M
RNST icon
591
Renasant Corp
RNST
$3.96B
$12.4M 0.02%
334,836
-342,464
-51% -$13M
MTB icon
592
M&T Bank
MTB
$36.1B
$12.3M 0.02%
62,307
+60,300
+3,004% +$11.8M
BLZRU
593
Trailblazer Acquisition Corp Unit
BLZRU
$205M
$12.3M 0.02%
+1,200,000
New +$12.1M
SLGN icon
594
Silgan Holdings
SLGN
$4.39B
$12.2M 0.02%
284,526
+135,493
+91% +$6.55M
OLED icon
595
Universal Display
OLED
$4.01B
$12.2M 0.02%
+85,000
New +$12.4M
DOC icon
596
Healthpeak Properties
DOC
$14.5B
$12.1M 0.02%
632,643
-3,700
-0.6% -$66.3K
HII icon
597
Huntington Ingalls Industries
HII
$12.7B
$12.1M 0.02%
41,929
-44,827
-52% -$11.9M
PCVX icon
598
Vaxcyte
PCVX
$8.5B
$12M 0.02%
+333,000
New +$11M
HIW icon
599
Highwoods Properties
HIW
$3.47B
$12M 0.02%
376,647
+15,000
+4% +$459K
ACHR icon
600
Archer Aviation
ACHR
$3.99B
$12M 0.02%
1,250,000
-2,500,000
-67% -$24.7M

Similar funds

Adage Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adage Capital Partners held 999 positions worth $63.1B, up 6.4% from $59.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Adage Capital Partners's Q3 2025 filing shows 156 new, 303 increased, 370 reduced and 127 closed positions. Its largest new stake was Chevron: 3,284,841 shares worth $510M. The largest sale was Hess, an estimated $1.35B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2025 buy was Chevron: 3,284,841 shares worth $510M.
  • Adage Capital Partners added most to Royalty Pharma in Q3 2025, an estimated $216M increase.
  • Adage Capital Partners's biggest Q3 2025 reduction was Insmed, cutting an estimated $197M.
  • Adage Capital Partners fully exited Hess in Q3 2025, selling an estimated $1.35B.
  • Adage Capital Partners's ten largest holdings make up 32% of its $63.1B portfolio in Q3 2025.
  • Adage Capital Partners opened 156 new positions and closed 127 in Q3 2025.
  • Adage Capital Partners's portfolio value rose 6.4% quarter-over-quarter to $63.1B.

Based on Adage Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.